Skip to content

Transient receptor potential cation channel subfamily M member 1 (TRPM1)

Homo sapiens — UniProt Q7Z4N2

Gene: TRPM1Homo sapiensSwissProt reviewedIon channel

Data last refreshed: (UniProt release unknown)

Key facts

Transient receptor potential cation channel subfamily M member 1 (TRPM1) is a protein from Homo sapiens identified by UniProt accession Q7Z4N2, 1603 residues long. MolForge cross-references it against 0 known binders and 158 disease associations.

  • UniProt accession: Q7Z4N2; gene symbol TRPM1.
  • Organism: Homo sapiens.
  • Length: 1603 amino acids.
  • Target class: Ion channel.
  • Top disease associations (Open Targets): congenital stationary night blindness, Retinal dystrophy and sunburn.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameTransient receptor potential cation channel subfamily M member 1
UniProt accessionQ7Z4N2
GeneTRPM1
OrganismHomo sapiens
Length1603 residues
Molecular weight—
EC numbers—
Target classIon channel (inferred from UniProt keywords / EC)
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (158)

Diseases linked to this target (Open Targets).

  • congenital stationary night blindness · score 0.70
  • Retinal dystrophy · score 0.48
  • sunburn · score 0.42
  • PHF-tau measurement · score 0.42
  • age-related macular degeneration · score 0.36
  • skin pigmentation · score 0.34
  • macula measurement · score 0.32
  • reticulocyte count · score 0.32
  • Red cell distribution width · score 0.32
  • protein measurement · score 0.31

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q7Z4N2-F1alphafoldPREDICTED66.28—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q7Z4N2.

Amino-acid sequence (1603 residues)

MKDSNRCCCG QFTNQHIPPL PSATPSKNEE ESKQVETQPE KWSVAKHTQS YPTDSYGVLE FQGGGYSNKA MYIRVSYDTK PDSLLHLMVK DWQLELPKLL ISVHGGLQNF EMQPKLKQVF GKGLIKAAMT TGAWIFTGGV STGVISHVGD ALKDHSSKSR GRVCAIGIAP WGIVENKEDL VGKDVTRVYQ TMSNPLSKLS VLNNSHTHFI LADNGTLGKY GAEVKLRRLL EKHISLQKIN TRLGQGVPLV GLVVEGGPNV VSIVLEYLQE EPPIPVVICD GSGRASDILS FAHKYCEEGG IINESLREQL LVTIQKTFNY NKAQSHQLFA IIMECMKKKE LVTVFRMGSE GQQDIEMAIL TALLKGTNVS APDQLSLALA WNRVDIARSQ IFVFGPHWPP LGSLAPPTDS KATEKEKKPP MATTKGGRGK GKGKKKGKVK EEVEEETDPR KIELLNWVNA LEQAMLDALV LDRVDFVKLL IENGVNMQHF LTIPRLEELY NTRLGPPNTL HLLVRDVKKS NLPPDYHISL IDIGLVLEYL MGGAYRCNYT RKNFRTLYNN LFGPKRPKAL KLLGMEDDEP PAKGKKKKKK KKEEEIDIDV DDPAVSRFQY PFHELMVWAV LMKRQKMAVF LWQRGEESMA KALVACKLYK AMAHESSESD LVDDISQDLD NNSKDFGQLA LELLDQSYKH DEQIAMKLLT YELKNWSNST CLKLAVAAKH RDFIAHTCSQ MLLTDMWMGR LRMRKNPGLK VIMGILLPPT ILFLEFRTYD DFSYQTSKEN EDGKEKEEEN TDANADAGSR KGDEENEHKK QRSIPIGTKI CEFYNAPIVK FWFYTISYLG YLLLFNYVIL VRMDGWPSLQ EWIVISYIVS LALEKIREIL MSEPGKLSQK IKVWLQEYWN ITDLVAISTF MIGAILRLQN QPYMGYGRVI YCVDIIFWYI RVLDIFGVNK YLGPYVMMIG KMMIDMLYFV VIMLVVLMSF GVARQAILHP EEKPSWKLAR NIFYMPYWMI YGEVFADQID LYAMEINPPC GENLYDEEGK RLPPCIPGAW LTPALMACYL LVANILLVNL LIAVFNNTFF EVKSISNQVW KFQRYQLIMT FHDRPVLPPP MIILSHIYII IMRLSGRCRK KREGDQEERD RGLKLFLSDE ELKRLHEFEE QCVQEHFREK EDEQQSSSDE RIRVTSERVE NMSMRLEEIN ERETFMKTSL QTVDLRLAQL EELSNRMVNA LENLAGIDRS DLIQARSRAS SECEATYLLR QSSINSADGY SLYRYHFNGE ELLFEDTSLS TSPGTGVRKK TCSFRIKEEK DVKTHLVPEC QNSLHLSLGT STSATPDGSH LAVDDLKNAE ESKLGPDIGI SKEDDERQTD SKKEETISPS LNKTDVIHGQ DKSDVQNTQL TVETTNIEGT ISYPLEETKI TRYFPDETIN ACKTMKSRSF VYSRGRKLVG GVNQDVEYSS ITDQQLTTEW QCQVQKITRS HSTDIPYIVS EAAVQAEHKE QFADMQDEHH VAEAIPRIPR LSLTITDRNG MENLLSVKPD QTLGFPSLRS KSLHGHPRNV KSIQGKLDRS GHASSVSSLV IVSGMTAEEK KVKKEKASTE TEC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with TRPM1?

The strongest Open Targets associations for TRPM1 are congenital stationary night blindness, Retinal dystrophy, sunburn, PHF-tau measurement and age-related macular degeneration.

How long is the TRPM1 protein?

The Homo sapiens TRPM1 protein (UniProt Q7Z4N2) is 1603 amino acids long.

Browse: Targets: T · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Transient receptor potential cation channel subfamily M member 1 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ7Z4N2
GeneTRPM1
OrganismHomo sapiens
Length1603
Binders0
Diseases158
View on UniProt